Cognition and Its Association with Psychosocial and Occupational Functioning during Treatment with Escitalopram in Patients with Major Depressive Disorder: A CAN-BIND-1 Report: La Cognition Et Son Association Avec Le Fonctionnement Psychosocial Et Professionnel Durant Le Traitement Par Escitalopram Chez Des Patients Souffrant De Trouble Dépressif Majeur: Une Étude Can-Bind-1
Author(s) -
Shane McInerney,
Trisha Chakrabarty,
Małgorzata Maciukiewicz,
Benício N. Frey,
Glenda MacQueen,
Roumen Milev,
Arun Ravindran,
Susan Rotzinger,
Sidney H. Kennedy,
Raymond W. Lam
Publication year - 2020
Publication title -
the canadian journal of psychiatry
Language(s) - French
Resource type - Journals
SCImago Journal Rank - 1.68
H-Index - 117
eISSN - 1497-0015
pISSN - 0706-7437
DOI - 10.1177/0706743720974823
Subject(s) - psychosocial , leaps , escitalopram , major depressive disorder , cognition , psychology , depression (economics) , clinical psychology , psychiatry , antidepressant , anxiety , macroeconomics , financial economics , economics
Major depressive disorder (MDD) is associated with impairments in both cognition and functioning. However, whether cognitive deficits significantly contribute to impaired psychosocial and occupational functioning, independent of other depressive symptoms, is not well established. We examined the relationship between cognitive performance and functioning in depressed patients before and after antidepressant treatment using secondary data from the first Canadian Biomarker Integration Network in Depression-1 study.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom